|
|
|
51-200 employees
View all
|
|
biotechnology
|
|
5858 Horton Street,Emeryville,CA,US
|
|
Eureka Therapeutics is a privately held biotechnology company located in the San Francisco Bay Area, focused on breakthrough immunotherapies for the treatment of cancer. Utilizing our antibody drug discovery and engineering technologies, we are advancing safe and effective therapies for targeting previously inaccessible cancer antigens. We have built an early stage pipeline of innovative drugs, with the most advanced candidates at pre-clinical stage. Eureka Therapeutics is a leader in the discovery of novel antibody immunotherapies. We utilize a paradigm-changing technology platform to develop fully-human antibodies against intracellular cancer antigens. In collaboration with Memorial Sloan-Kettering Cancer Center, we were the first-to-demonstrate in vivo efficacy of a human IgG1 antibody against an intracellular cancer antigen. Our most advanced program is at preclinical stage and being developed in partnership with Novartis.
|
Eureka Therapeutics, Inc Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Eureka Therapeutics, Inc email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Eureka Therapeutics, Inc customer service number in your country click here to find.
Cheng Liu is the CEO of Eureka Therapeutics, Inc. To contact Cheng Liu email at [email protected] or [email protected]. Or you may call +1.5106547045 or +1.5103347840
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.